Psychotherapeutic drugs market is
comprised of drugs which are used to treat mental illnesses such as confused
thinking, extreme mood swings, long lasting depression, social withdrawal and
suicidal thought. Commonly found mental disorders are schizophrenia, bipolar disorder,
anxiety and depression. Schizophrenia is a mental disease associated with
hearing voices, unorganized speech and broken thoughts. Depression is a common
disorder characterized by lack of confidence, pleasure and interest.
To
Read The Complete Report with TOC : http://www.marketresearchreports.biz/analysis-details/psychotherapeutic-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The global Psychotherapeutic Drugs
Market is segmented on the basis of various therapeutic classes used to treat
mental illness such as antipsychotics (chlorpromazine, haloperidol),
antidepressants (amitriptyline, clomipramine), antimaniacs (lithium,
carbamazepine) and anxiety drugs (lorazepam, alprazolam). Antipsychotic is one
of the fastest growing segments owing to increasing incidences of mental
disorders such as schizophrenia and bipolar disorder. Atypical antipsychotics
are the most preferred antipsychotics because they are more efficacious than
first generation antipsychotics. Top selling antipsychotic drugs are Abilify,
Seroquel, Risperdal and Zyprexa.
The global psychotherapeutic drugs
market is growing worldwide due to high prevalence of emotional and mental
diseases. According to WHO report approximately 350 million people are
suffering from depression and around 24 million people are affected by
schizophrenia around the world as of today. Patent expiration of top psychotic
drugs Prozac, Geodon and Zyprexia has opened way for generic manufacturers and
it is expected that in coming years generic segment will rise dramatically and
will give rise price competition in the psychotherapeutic drugs market.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment